His research interests include the development of new methods in organic synthesis, synthesis of bioactive natural products and medicinal chemistry. He leads the Bioactive Molecule Synthesis group, who develop new strategies for the synthesis of 3D, stereochemically rich compounds for drug discovery, synthesise new anti-malarial and anticancer compounds and, with collaborators, explore their mechanisms of action.